Cargando…

Phenotype and Metabolic Disorders in Polycystic Ovary Syndrome

The polycystic ovary syndrome (PCOS) is one of the most frequent endocrinopathies in women. Its incidence is assessed at 6–8% of the female population in the reproductive age. It is characterised by oligomenorrhea (Oligo), hyperandrogenism (HA), and the presence of polycystic ovaries (PCOs). Carbohy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Głuszak, Olgierd, Stopińska-Głuszak, Urszula, Glinicki, Piotr, Kapuścińska, Renata, Snochowska, Hanna, Zgliczyński, Wojciech, Dębski, Romuald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3302054/ https://www.ncbi.nlm.nih.gov/pubmed/22462015 http://dx.doi.org/10.5402/2012/569862

Ejemplares similares

Transport of deoxy-d-glucose into lymphocytes of patients with polycystic ovary syndrome
por: Oleszczak, Bożenna, et al.
Publicado: (2014)

Commentary to “Chromogranin A: Biological Function and Clinical Utility in Neuroendocrine Tumor Disease”
por: Jeske, Wojciech, et al.
Publicado: (2010)

Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review
por: Jakielska, Ewelina, et al.
Publicado: (2023)

Poor Performance of Angiotensin II Enzyme-Linked Immuno-Sorbent Assays in Mostly Hypertensive Cohort Routinely Screened for Primary Aldosteronism
por: Łebek-Szatańska, Agnieszka, et al.
Publicado: (2022)

Musculoskeletal complications of Cushing syndrome
por: Leszczyńska, Dorota, et al.
Publicado: (2023)

Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society – state of knowledge as of December 2013
por: Bińkowska, Małgorzata, et al.
Publicado: (2014)

Improvements in Quality of Life and Thyroid Parameters in Hypothyroid Patients on Ethanol-Free Formula of Liquid Levothyroxine Therapy in Comparison to Tablet LT4 Form: An Observational Study
por: Bornikowska, Katarzyna, et al.
Publicado: (2021)

The glucose metabolism disorder and dyslipidemia among girls with different phenotype polycystic ovary syndrome
por: Akbarzadeh, Marzieh, et al.
Publicado: (2019)

Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort
por: Dao Trong, P., et al.
Publicado: (2023)

Epstein-Barr Virus and Human Adenovirus Viremia in Renal Tumors Is Associated with Histological Features of Malignancy
por: Kryst, Piotr, et al.
Publicado: (2020)

FGF21 Is Released During Increased Lipogenesis State Following Rapid-Onset Radioiodine-Induced Hypothyroidism
por: Szczepańska, Ewa, et al.
Publicado: (2022)

Menopausal hormone therapy in questions and answers – a manual for physicians of various specialties
por: Paszkowski, Tomasz, et al.
Publicado: (2019)

Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm
por: Paalanne, Marika, et al.
Publicado: (2021)

Extended High Frequency Audiometry in Polycystic Ovary Syndrome
por: Kucur, Cuneyt, et al.
Publicado: (2013)

Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione
por: O'Reilly, Michael W., et al.
Publicado: (2014)

Polycystic Ovary Syndrome and Psychotic Disorder
por: Doretto, Larissa, et al.
Publicado: (2020)

The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran
por: Ramezani Tehrani, Fahimeh, et al.
Publicado: (2014)

Correlation Between Hemoglobin Levels and Polycystic Ovary Syndrome Metabolic Disorder
por: Ha, Ling-Xia, et al.
Publicado: (2023)

Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects
por: Leutner, Michael, et al.
Publicado: (2018)

The Effects of Oral Isotretinoin in Women with Acne and Polycystic Ovary Syndrome
por: Acmaz, G., et al.
Publicado: (2019)

Obesity Differentially Affects Phenotypes of Polycystic Ovary Syndrome
por: Moran, Carlos, et al.
Publicado: (2012)

Polycystic Ovary Syndrome and Gut Microbiota: Phenotype Matters
por: Suturina, Larisa, et al.
Publicado: (2022)

Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis
por: Zhao, Yue, et al.
Publicado: (2012)

Hyperandrogenemia in Polycystic Ovary Syndrome: Exploration of the Role of Free Testosterone and Androstenedione in Metabolic Phenotype
por: Lerchbaum, Elisabeth, et al.
Publicado: (2014)

Sex modifies the effect of genetic risk scores for polycystic ovary syndrome on metabolic phenotypes
por: Actkins, Ky’Era V., et al.
Publicado: (2023)

A Rat Model of Maternal Polycystic Ovary Syndrome Shows that Exposure to Androgens In Utero Results in Dysbiosis of the Intestinal Microbiota and Metabolic Disorders of the Newborn Rat
por: Gulan, Tuohetimulati, et al.
Publicado: (2019)

Circulating ANGPTL8 Is Associated with the Presence of Metabolic Syndrome and Insulin Resistance in Polycystic Ovary Syndrome Young Women
por: Pu, Danlan, et al.
Publicado: (2019)

Metabolic effects of polycystic ovary syndrome in adolescents
por: Han, Yejin, et al.
Publicado: (2015)

Cortisol-Metabolizing Enzymes in Polycystic Ovary Syndrome
por: Blumenfeld, Zeev, et al.
Publicado: (2016)

Metabolic Deregulations in Patients with Polycystic Ovary Syndrome
por: Jabczyk, Marzena, et al.
Publicado: (2023)

Polycystic Ovary Syndrome May Be an Autoimmune Disorder
por: Mobeen, Hifsa, et al.
Publicado: (2016)

Endometriosis and polycystic ovary syndrome are diametric disorders
por: Dinsdale, Natalie L., et al.
Publicado: (2021)

Characteristics and possible mechanisms of metabolic disorder in overweight women with polycystic ovary syndrome
por: Yu, Jin, et al.
Publicado: (2023)

Evaluation of plasma ACTH in the metyrapone test is insufficient for the diagnosis of secondary adrenal insufficiency
por: Papierska, Lucyna, et al.
Publicado: (2022)

Cardiovascular Risk Factors in Bulgarian Patients with Polycystic Ovary Syndrome and/or Obesity
por: Gateva, Antoaneta, et al.
Publicado: (2012)

Retinal Nerve Fiber Layer Thickness in Women with Polycystic Ovary Syndrome
por: Demir, Mehmet, et al.
Publicado: (2013)

Preventive online and offline health management intervention in polycystic ovary syndrome
por: Liu, Rui, et al.
Publicado: (2022)

Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women
por: Dadachanji, Roshan, et al.
Publicado: (2021)

Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health
por: Mills, Edouard G., et al.
Publicado: (2023)

Awareness of polycystic ovary syndrome: A university students’ perspective
por: Alshdaifat, Eman, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vinqkf8vp3rcb8f9flmutdjvcm